title: Eptifibatide-induced profound thrombocytopenia.
abstract: We report a case of profound thrombocytopenia, 2 hours following eptifibatide therapy which got reversed within 12 hours of discontinuation of eptifibatide.
authors.affiliation: Department of Invasive Cardiology, Escorts Heart Institute and Research Centre, New Delhi.
authors.forename: N
authors.initials: N
authors.lastname: Gupta
authors.forename: R
authors.initials: R
authors.lastname: Kapoor
authors.forename: S
authors.initials: S
authors.lastname: Bhandari
mesh_terms: D017023:Coronary Angiography / Q000009:adverse effects; D003907:Dexamethasone / Q000627:therapeutic use; D000077542:Eptifibatide; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007262:Infusions, Intravenous; D008875:Middle Aged; D010455:Peptides / Q000008:administration & dosage / Q000009:adverse effects*; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage / Q000009:adverse effects; D011379:Prognosis; D013921:Thrombocytopenia / Q000188:drug therapy / Q000209:etiology*; D016896:Treatment Outcome
chemical_list: D005938:Glucocorticoids; D010455:Peptides; D010975:Platelet Aggregation Inhibitors; D003907:Dexamethasone; D000077542:Eptifibatide